Pegylated Interferon-associated Retinopathy in Chronic Hepatitis C Patients

Overview

Journal Jpn J Ophthalmol

Specialty Ophthalmology

Date 2006 Jun 13

PMID 16767392

Citations 2

Authors

Hiroko Ogata

Hiromasa Suzuki

Kimiya Shimizu

Hitoshi Ishikawa

Namiki Izumi

Masayuki Kurosaki

Affiliations

Soon will be listed here.

Citing Articles

Ophthalmologic complications of antiviral therapy in hepatitis C treatment.

ODay R, Gillies M, Ahlenstiel G World J Gastroenterol. 2013; 19(45):8227-37.

PMID: 24363513 PMC: 3857445. DOI: 10.3748/wjg.v19.i45.8227.

Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin.

Kim E, Kim L, Lee J, Chin H Jpn J Ophthalmol. 2009; 53(6):598-602.

PMID: 20020238 DOI: 10.1007/s10384-009-0738-8.

References

Zeuzem S, Feinman S, Rasenack J, Heathcote E, Lai M, Gane E . Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med. 2000; 343(23):1666-72. DOI: 10.1056/NEJM200012073432301. View

Kondo Y, Tateishi R, Yoshida H, Omata M . [Effectiveness of long-acting interferon (peginterferon)]. Nihon Rinsho. 2004; 62 Suppl 7(Pt 1):515-8. View

Chuman T, Nao-i N, Sawada A, Kawano T, Shigehira M . [Interferon-induced retinal changes]. Nippon Ganka Gakkai Zasshi. 1994; 98(6):616-21. View